Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SUMMER INFAN | SUMR | 8.43% |
| SCIENTIFIC L | SCIL | 8.00% |
| FEDERAL MOGU | FDML | 6.02% |
| NATUS MEDICA | BABY | 5.62% |
| NEW ORIENTAL | EDU | 5.36% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
• Expedia Inc. (NASDAQ:EXPE) announced that its chief financial officer, Michael Adler, will vacate his position after the spin-off of TripAdvisor, and will be replaced by Mark Okerstrom, currently senior vice president of corporate development
• Houston-based specialty-chemicals maker KMG Chemicals Inc. (NASDAQ:KMGB) said that it expects fourth-quarter profit to be roughly half of what it earned in its latest quarter
• Coal producer Peabody Energy Corp. (NYSE:BTU) announced that its third quarter earnings could be lower as a result of production stoppages in an Australian mine
• Finisar Corp. (NASDAQ:FNSR) reported first-quarter earnings per share of $0.21, beating the Zacks Consensus Estimate of $0.17
• Liz Claiborne Inc. (NYSE:LIZ) announced that it will sell its Mexx business to a joint venture led by the Gores Group, a private-equity firm. Liz Claiborne will receive $85 million and an 18.75% stake in the joint venture
• H&R Block, Inc. (NYSE:HRB) reported an adjusted loss of $0.37 per share in fiscal first-quarter 2012 ending July 31, narrower than the Zacks Consensus Estimate of a loss of $0.39
• Esterline Technologies Corp. (NYSE:ESL) reduced its full year earnings estimates to a maximum of $4.55 per share
• According to reports, The Federal Housing Finance Agency is filing a lawsuit against Bank of America Corporation (NYSE:BAC), JPMorgan Chase & Co. (NYSE:JPM) and The Goldman Sachs Group, Inc. (NYSE:GS) among other big lenders, accusing them of unfair mortgage practices
Read the full reports :
Analyst Report on EXPE
Analyst Report on BTU
Snapshot Report on FNSR
Analyst Report on HRB
Snapshot Report on ESL
Analyst Report on BAC
Analyst Report on JPM
Analyst Report on GS